LUMIZYME (alglucosidase alfa) for Injection

First Page		Document Content
Date: 2010-05-26 09:39:24 Clinical medicine Neurochemistry Medicine Sodium channel blockers Alglucosidase alfa Calcium channel blockers Glycogen storage disease type II Ketamine Treprostinil Eptifibatide		LUMIZYME (alglucosidase alfa) for Injection Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 245,04 KB Share Document on Facebook

	LUMIZYME (alglucosidase alfa) for Injection DocID: 1qeuI - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. ® DocID: 19v3z - View Document
	A randomized, open-label trial of edoxaban in Japanese patients with severe renal impairment undergoing lower-limb orthopedic surgery DocID: 16tjh - View Document
	Reprint from January 8, 2007 BioCentury THE BERNSTEIN REPORT ARTICLE REPRINT DocID: 13F1b - View Document
	PRESS RELEASE Sanofi Provides Update on Phase 3 Studies of Two Investigational Compounds Paris, France - June 3, [removed]Sanofi (EURONEXT: SAN and NYSE: SNY) today announced topline results of two Phase 3 clinical studie DocID: RQch - View Document